Evidence map›Paper›PMID 36403926›Full record

ArticleOphthalmology. Retina2023

Hyperreflective Foci in Age-Related Macular Degeneration are Associated with Disease Severity and Functional Impairment.

Cameron Duic, Kristina Pfau, Tiarnan D L Keenan, Henry Wiley, Alisa Thavikulwat, Emily Y Chew, Catherine Cukras

Abstract read
In one paragraph

Article in Ophthalmology. Retina, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Review
  12. Structural OCT and OCT angiography biomarkers associated with the development and progression of geographic atrophy in AMD.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Cameron DuicUnit on Clinical Investigation of Retinal Diseases, National Eye Institute, National Institute of Health, Bethesda, Maryland.
Kristina PfauUnit on Clinical Investigation of Retinal Diseases, National Eye Institute, National Institute of Health, Bethesda, Maryland; Department of Ophthalmology, University Hospital Bonn, Bonn, Germany.
Tiarnan D L KeenanDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institute of Health, Bethesda, Maryland.
Henry WileyDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institute of Health, Bethesda, Maryland.
Alisa ThavikulwatDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institute of Health, Bethesda, Maryland.
Emily Y ChewDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institute of Health, Bethesda, Maryland.
Catherine CukrasUnit on Clinical Investigation of Retinal Diseases, National Eye Institute, National Institute of Health, Bethesda, Maryland. Electronic address: cukrasc@nei.nih.gov.
National Eye Institute · USUniversity Hospital Bonn · DE

Funding

Longitudinal Investigation of Dark Adaptation in Participants with AMDZIAEY000509 · NEI · NATIONAL EYE INSTITUTE · PI CUKRAS, CATHERINE · 2011 to 2025
$2.5M
Intramural NIH HHS ZIA EY000509
6 · The paper itself

Abstract

purposeTo analyze presence of hyperreflective foci (HRF) across different age-related macular degeneration (AMD) severities and examine its correlation with other structural and functional AMD features.

designLongitudinal, single-center, case-control study.

participantsOne hundred and fifty-eight participants aged > 50 years old with varying AMD severities (including no AMD).

methodsColor fundus imaging was used to assess AMD severity and hyperpigmentation (PGM) presence. Subretinal drusenoid deposits (SDD) and HRF were detected on OCT volumes. The correlations of HRF with additional AMD features were evaluated using linear and logistic mixed-effects models. One study eye per participant underwent dark adaptation (DA) testing to measure rod intercept time (RIT) for structure function associations. Eyes were followed longitudinally and changes in AMD severity and RIT were measured relative to HRF presence.

main outcome measuresThe primary outcome was presence of HRF, which was compared with presence of other AMD features and DA impairment.

resultsOne hundred and fifty-eight participants (median baseline age of 73.1 [interquartile range (IQR) = 66-79] years) contributing 1277 eye visits were included. Hyperreflective foci (HRF) were detected more frequently in higher AMD severities. Hyperreflective-foci presence was significantly associated with PGM presence (odds ratio 832.9, P < 0.001) and SDD presence (odds ratio 9.42, P = 0.017). Eyes with HRF demonstrated significantly longer DA (median 27.1 [IQR = 16-40] minutes) than those without HRF (13.5 [10-22] minutes) but less than eyes with SDD only (40 [28-40] minutes). Highest RIT values were found in eyes with both HRF and SDD (40.0 [40-40] minutes). Age and HRF explained a similar proportion of RIT variability as age and SDD. Eyes that developed HRF demonstrated baseline RITs closer to eyes with HRF at baseline, compared with eyes that never developed HRF (29.1 [16-40], 38.5 [22-40] versus 13.1 [10-22] minutes; Kruskal-Wallis P < 0.001).

conclusionsThe progressively increased presence of HRF in higher AMD severities, and its correlation with previously associated AMD biomarkers, suggests HRF is an important OCT feature adding to the understanding of disease progression. Hyperreflective foci presence was associated with delays in DA, indicating HRF is a marker for visual cycle impairment. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

Indexed as

Macular DegenerationRetinal DrusenAgedCase-Control StudiesHumansMiddle AgedPatient AcuityTomography, Optical CoherenceAge-related macular degeneration(AMD)(DA)Dark adaptation(HRF)HyperpigmentationHyperreflective foci(PGM)(SDD)Subretinal drusenoid deposits

Identifiers

PMID36403926
PMCPMC13448161
OpenAlexW4309515445

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.